Advertisement
Home Tags Cancer: Prostate

Tag: Cancer: Prostate

A lesion visible on magnetic resonance imaging identifies a heightened risk for clinically significant prostate cancer in men undergoing first-time prostate biopsy

Combination Biopsy Strategy May Identify More Prostate Cancers

0
Lesion-targeted plus systematic sampling appears to maximize the accuracy of first-time prostate biopsy
After adjustment for nonbiological differences

Black Race Not Tied to Worse Prostate Cancer Mortality

0
Findings seen in cohorts of men with nonmetastatic disease after adjusting for nonbiological differences
Specific fat deposits

Location of Body Fat Linked to Advanced, Fatal Prostate Cancer

0
Risk for advanced, fatal disease also increased in association with body mass index, waist circumference
Overall rates of active surveillance are up for all men with low-risk prostate cancer

Fewer Black Men Adopt Active Surveillance for Prostate Cancer

0
Overall, use of active surveillance nearly tripled among both black and nonblack men from 2010 to 2015
For men with metastatic

ASCO: Enzalutamide Beneficial in Metastatic Prostate Cancer

0
Progression-free, overall survival longer for men with metastatic, hormone-sensitive prostate cancer
Clinical guidelines on adjuvant and salvage radiotherapy after radical prostatectomy have been updated

Guidelines Updated for Radiotherapy After Prostatectomy

0
Updates include adjuvant radiotherapy for patients with adverse pathologic findings, hormonal therapies

American Urological Association, May 3-6

0
The American Urological Association 2019 Annual Meeting The annual meeting of the American Urological Association was held from May 3 to 6 in...
Atenolol is associated with a reduction in incident intermediate- and low-risk prostate cancer

AUA: Atenolol Linked to Drop in Low-, Intermediate-Risk Prostate Cancer

0
After adjustment for confounders, atenolol displayed significant protective effect on prostate cancer
Single-dose high dose-rate brachytherapy is safe and effective for low-risk prostate cancer

Single-Dose Brachytherapy Effective for Prostate Cancer

0
Two-year and three-year biochemical progression-free survival rate of 100 percent for low-risk disease
Focal laser ablation of low- to intermediate-risk prostate cancer is associated with low morbidity and good oncologic outcomes

Morbidity Low With Focal Laser Ablation of Prostate Cancer

0
Tumor diameter above the median was only significant predictor for positive MRI after treatment